Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

international-2693231_1920

Japan approves Moderna & AstraZeneca COVID-19 vaccines

May 21, 2021 Medical Communications COVID-19, Japan, Vaccine

A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
News

Dogs can detect COVID-19 with 97% accuracy, study finds

May 21, 2021 Medical Communications

A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 21, 2021 Medical Communications

Among our ten most-read stories this week: Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows, while a …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 14, 2021 Medical Communications

Among our ten most-read stories this week: India recoded its record number of COVID-19 deaths, with 4,205 fatalities confirmed in …
News

MSD’s colorectal cancer treatment approved by NICE

May 14, 2021 Medical Communications

Pembrolizumab (Keytruda), for people with untreated metastatic colorectal cancer who have specific mutations in their cancer cells, has been approved …
News
Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

May 14, 2021 Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …
News
biogen_austria_238

Biogen to collaborate with Envisagenics on RNA splicing research

May 14, 2021 Medical Communications AI

Biogen and Envisagenics have announced a new collaboration to advance ribonucleic acid (RNA) splicing research within central nervous system (CNS) …
News

Major ovarian cancer screening trial fails to reduce deaths

May 14, 2021 Medical Communications

A major trial involving 200,000 women to detect ovarian cancer has failed to save lives after two decades of work. …
News
Pharmafile's top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

May 7, 2021 Medical Communications covid 19 news, covid-19 news, news round up, pharma, pharma news, top 10

Among our ten most-read stories this week: NICE has announced that more patients are eligible for a £75,000-a-vial SMA drug, …
News

Merck kidney and uterus cancer treatments granted priority review by FDA

May 7, 2021 Medical Communications FDA, MSD, Merck, cancer treatment, kidney cancer treatment, pharma, pharma news, uterus cancer treatment

The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …
News

Deloitte acquires Iperion Life Sciences Consultancy

May 7, 2021 Medical Communications marketing, sales

Deloitte have announced the acquisition of Iperion Life Sciences Consultancy, a globally-operating firm working to support life sciences companies and …
News
astrazeneca_sign_sky

AstraZeneca secures MHRA licensing and NHS early access for lung cancer drug

May 7, 2021 Medical Communications Astrazenaca, oncology

AstraZeneca have announced that the MHRA has granted a license extension for Tagrisso (osimertinib) in the UK, for use as …
News
pexels-nappy-3584086

Biomarker linked to male hair loss found to determine COVID-19 severity

May 7, 2021 Medical Communications COVID-19, hair loss

Findings presented at the European Academy of Dermatology and Venereology (EADV) Spring Symposium suggest that men with genetic characteristics (phenotypes) …
News
Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

April 30, 2021 Medical Communications COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

Among our top 10 stories this week: In COVID news, an app has revealed the most common side effects for …
News

Celltrion’s COVID-19 treatment shows promise against South African variant

April 30, 2021 Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news

Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026